{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T23:16:20Z","timestamp":1768346180799,"version":"3.49.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,4,20]],"date-time":"2025-04-20T00:00:00Z","timestamp":1745107200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,20]],"date-time":"2025-04-20T00:00:00Z","timestamp":1745107200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000026","name":"U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA030005"],"award-info":[{"award-number":["R01DA030005"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["R01AA023534"],"award-info":[{"award-number":["R01AA023534"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2020-01175"],"award-info":[{"award-number":["2020-01175"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2021-06467"],"award-info":[{"award-number":["2021-06467"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Researchers selecting probands for molecular genetic studies confront a range of sampling issues with modest empirical guidance. In this paper, using cases of major depression (MD), anxiety disorders (AD) alcohol use disorder (AUD), drug use disorder (DUD), bipolar disorder (BD) and schizophrenia (SZ) from a large population cohort of all native Swedes born 1940\u20132003, we examine the implications of three proband selection decisions by exploring profiles of genetic risks assessed using the validated family genetic risk scores. The impact of censoring cases with comorbid diagnoses is quite variable, depending on the frequency of that disorder in the case sample and the genetic relationship of the censored to the primary disorder. In an MD cohort, censoring SZ cases produces only a focal small decrease in schizophrenia genetic risk while censoring AD cases produces a wide-spread reduction in genetic risk for MD and most other disorders. We examine the value of censoring cases of SZ, BD and MD whose onset was preceded by one to two years by first episodes of DUD or AUD. We do not see any increase in genetic risk for these \u201cscreened\u201d cohorts. Secondary ascertainment, where disorder A is ascertained as a comorbid diagnosis in a sample collected for disorder B, can, in certain situations, produces large increases in the genetic risk for disorder B and associated disorders in cases of A. However, if disorder B is closely genetically related to disorder A (as seen with MD\/AD and DUD\/AUD pairings), the pattern differs dramatically and produces a general moderate elevation across the genetic risk profile. These findings provide guidelines for future investigators and suggest caution when screening out comorbid disorders and when utilizing secondary ascertainment.<\/jats:p>","DOI":"10.1038\/s41380-025-03015-y","type":"journal-article","created":{"date-parts":[[2025,4,20]],"date-time":"2025-04-20T01:23:11Z","timestamp":1745112191000},"page":"4334-4342","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Exploring the implications of case selection methods for psychiatric molecular genetic studies"],"prefix":"10.1038","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8689-6570","authenticated-orcid":false,"given":"Kenneth S.","family":"Kendler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik","family":"Ohlsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7228-5015","authenticated-orcid":false,"given":"Jan","family":"Sundquist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristina","family":"Sundquist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,20]]},"reference":[{"key":"3015_CR1","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/gepi.22281","volume":"44","author":"KS Kendler","year":"2020","unstructured":"Kendler KS, Chatzinakos C, Bacanu SA. The impact on estimations of genetic correlations by the use of super-normal, unscreened, and family-history screened controls in genome wide case-control studies. Genet Epidemiol. 2020;44:283\u20139.","journal-title":"Genet Epidemiol"},{"key":"3015_CR2","doi-asserted-by":"publisher","unstructured":"Benstock SE, Weaver K, Hettema JM, Verhulst B. Using alternative definitions of controls to increase statistical power in GWAS. Behav Genet. 2024:1\u201314. https:\/\/doi.org\/10.21203\/rs.3.rs-3858178\/v1.","DOI":"10.21203\/rs.3.rs-3858178\/v1"},{"key":"3015_CR3","unstructured":"Kessler RC. The prevalence of psychiatric comorbidity. In: Wetzler S, Sanderson WC, editors. Treatment strategies for patients with psychiatric comorbidity. New York, NY: John Wiley & Sons, Inc.; 1997. p. 23\u201348."},{"key":"3015_CR4","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1001\/archpsyc.62.6.617","volume":"62","author":"RC Kessler","year":"2005","unstructured":"Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:617\u201327.","journal-title":"Arch Gen Psychiatry"},{"key":"3015_CR5","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1001\/archpsyc.64.5.566","volume":"64","author":"WM Compton","year":"2007","unstructured":"Compton WM, Thomas YF, Stinson FS, Grant BF. Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry. 2007;64:566\u201376.","journal-title":"Arch Gen Psychiatry"},{"key":"3015_CR6","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1001\/jama.1990.03450190043026","volume":"264","author":"DA Regier","year":"1990","unstructured":"Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA. 1990;264:2511\u20138.","journal-title":"JAMA"},{"key":"3015_CR7","unstructured":"Merikangas KR, Angst J, Eaton W, Canino G, Rubio-Stipec M, Wacker H, et al. Comorbidity and boundaries of affective disorders with anxiety disorders and substance misuse: results of an international task force."},{"key":"3015_CR8","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1176\/ajp.152.4.571","volume":"152","author":"JM Oldham","year":"1995","unstructured":"Oldham JM, Skodol AE, Kellman HD, Hyler SE, Doidge N, Rosnick L, et al. Comorbidity of axis I and axis II disorders. Am J Psychiatry. 1995;152:571\u20138.","journal-title":"Am J Psychiatry"},{"key":"3015_CR9","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1007\/s00127-008-0490-2","volume":"44","author":"K Crebbin","year":"2009","unstructured":"Crebbin K, Mitford E, Paxton R, Turkington D. First-episode drug-induced psychosis: a medium term follow up study reveals a high-risk group. Soc Psychiatry Psychiatr Epidemiol. 2009;44:710\u20135.","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"3015_CR10","doi-asserted-by":"publisher","first-page":"e94","DOI":"10.4088\/JCP.12m07822","volume":"74","author":"JA Niemi-Pynttari","year":"2013","unstructured":"Niemi-Pynttari JA, Sund R, Putkonen H, Vorma H, Wahlbeck K, Pirkola SP. Substance-induced psychoses converting into schizophrenia: a register-based study of 18,478 Finnish inpatient cases. J Clin Psychiatry. 2013;74:e94\u2013e9.","journal-title":"J Clin Psychiatry"},{"key":"3015_CR11","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1176\/appi.ajp.2019.18101217","volume":"176","author":"KS Kendler","year":"2019","unstructured":"Kendler KS, Ohlsson H, Sundquist J, Sundquist K. Prediction of onset of substance-induced psychotic disorder and its progression to schizophrenia in a Swedish national sample. Am J Psychiatry. 2019;176:711\u20139.","journal-title":"Am J Psychiatry"},{"key":"3015_CR12","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1192\/bjp.187.6.510","volume":"187","author":"M Arendt","year":"2005","unstructured":"Arendt M, Rosenberg R, Foldager L, Perto G, Munk-Jorgensen P. Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: follow-up study of 535 incident cases. Br J Psychiatry. 2005;187:510\u20135.","journal-title":"Br J Psychiatry"},{"key":"3015_CR13","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.biopsych.2013.08.034","volume":"76","author":"J Gelernter","year":"2014","unstructured":"Gelernter J, Kranzler HR, Sherva R, Koesterer R, Almasy L, Zhao H, et al. Genome-wide association study of opioid dependence: multiple associations mapped to calcium and potassium pathways. Biol Psychiatry. 2014;76:66\u201374.","journal-title":"Biol Psychiatry"},{"key":"3015_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-21003-y","volume":"12","author":"N Gaddis","year":"2022","unstructured":"Gaddis N, Mathur R, Marks J, Zhou L, Quach B, Waldrop A, et al. Multi-trait genome-wide association study of opioid addiction: OPRM1 and beyond. Sci Rep. 2022;12:16873.","journal-title":"Sci Rep"},{"key":"3015_CR15","doi-asserted-by":"publisher","unstructured":"Strom NI, Verhulst B, Bacanu S-A, Cheesman R, Purves KL, Gedik H, et al. Genome-wide association study of major anxiety disorders in 122,341 European-ancestry cases identifies 58 loci and highlights GABAergic signaling. medRxiv [Preprint] 2024; e-pub ahead of print; https:\/\/doi.org\/10.1101\/2024.07.03.24309466; https:\/\/www.medrxiv.org\/content\/10.1101\/2024.07.03.24309466v1 (accessed 3 September 2024).","DOI":"10.1101\/2024.07.03.24309466"},{"key":"3015_CR16","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1001\/jamapsychiatry.2021.0336","volume":"78","author":"KS Kendler","year":"2021","unstructured":"Kendler KS, Ohlsson H, Sundquist J, Sundquist K. Family genetic risk scores and the genetic architecture of major affective and psychotic disorders in a Swedish national sample. JAMA Psychiatry. 2021;78:735\u201343.","journal-title":"JAMA Psychiatry"},{"key":"3015_CR17","doi-asserted-by":"publisher","first-page":"3448","DOI":"10.1017\/S0033291721005535","volume":"53","author":"KS Kendler","year":"2023","unstructured":"Kendler KS, Ohlsson H, Bacanu S, Sundquist J, Sundquist K. Differences in genetic risk score profiles for drug use disorder, major depression, and ADHD as a function of sex, age at onset, recurrence, mode of ascertainment, and treatment. Psychol Med. 2023;53:3448\u201360.","journal-title":"Psychol Med"},{"key":"3015_CR18","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1017\/S0033291721003354","volume":"53","author":"KS Kendler","year":"2023","unstructured":"Kendler KS, Ohlsson H, Moscicki EK, Sundquist J, Edwards AC, Sundquist K. Genetic liability to suicide attempt, suicide death, and psychiatric and substance use disorders on the risk for suicide attempt and suicide death: a Swedish national study. Psychol Med. 2023;53:1639\u201348.","journal-title":"Psychol Med"},{"key":"3015_CR19","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1017\/S0033291721004268","volume":"53","author":"KS Kendler","year":"2023","unstructured":"Kendler KS, Ohlsson H, Sundquist J, Sundquist K. Impact of comorbidity on family genetic risk profiles for psychiatric and substance use disorders: a descriptive analysis. Psychol Med. 2023;53:2389\u201398.","journal-title":"Psychol Med"},{"key":"3015_CR20","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1038\/s41380-023-02365-9","volume":"29","author":"KS Kendler","year":"2024","unstructured":"Kendler KS, Ohlsson H, Sundquist J, Sundquist K. The relationship between familial-genetic risk and pharmacological treatment in a Swedish national sample of patients with major depression, bipolar disorder, and schizophrenia. Mol Psychiatry. 2024;29:742\u20139.","journal-title":"Mol Psychiatry"},{"key":"3015_CR21","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1038\/ng.2711","volume":"45","author":"SH Lee","year":"2013","unstructured":"Lee SH, Ripke S, Neale BM, Faraone SV, Purcell SM, Perlis RH, et al. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet. 2013;45:984\u201394.","journal-title":"Nat Genet"},{"key":"3015_CR22","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/s41588-022-01057-4","volume":"54","author":"AD Grotzinger","year":"2022","unstructured":"Grotzinger AD, Mallard TT, Akingbuwa WA, Ip HF, Adams MJ, Lewis CM, et al. Genetic architecture of 11 major psychiatric disorders at biobehavioral, functional genomic and molecular genetic levels of analysis. Nat Genet. 2022;54:548\u201359.","journal-title":"Nat Genet"},{"key":"3015_CR23","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1017\/S0033291706008385","volume":"36","author":"P Lichtenstein","year":"2006","unstructured":"Lichtenstein P, Bjork C, Hultman CM, Scolnick E, Sklar P, Sullivan PF. Recurrence risks for schizophrenia in a Swedish national cohort. Psychol Med. 2006;36:1417\u201325.","journal-title":"Psychol Med"},{"key":"3015_CR24","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/j.1600-0447.2011.01747.x","volume":"124","author":"C Sellgren","year":"2011","unstructured":"Sellgren C, Landen M, Lichtenstein P, Hultman CM, Langstrom N. Validity of bipolar disorder hospital discharge diagnoses: file review and multiple register linkage in Sweden. Acta Psychiatr Scand. 2011;124:447\u201353.","journal-title":"Acta Psychiatr Scand"},{"key":"3015_CR25","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/08039480500360906","volume":"59","author":"B Ekholm","year":"2005","unstructured":"Ekholm B, Ekholm A, Adolfsson R, Vares M, Osby U, Sedvall GC, et al. Evaluation of diagnostic procedures in Swedish patients with schizophrenia and related psychoses. Nord J Psychiatry. 2005;59:457\u201364.","journal-title":"Nord J Psychiatry"},{"key":"3015_CR26","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.schres.2018.08.001","volume":"204","author":"V Johansson","year":"2019","unstructured":"Johansson V, Hultman CM, Kizling I, Martinsson L, Borg J, Hedman A, et al. The schizophrenia and bipolar twin study in Sweden (STAR). Schizophr Res. 2019;204:183\u201392.","journal-title":"Schizophr Res"},{"key":"3015_CR27","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1176\/appi.ajp.2018.17111251","volume":"175","author":"KS Kendler","year":"2018","unstructured":"Kendler KS, Ohlsson H, Lichtenstein P, Sundquist J, Sundquist K. The genetic epidemiology of treated major depression in Sweden. Am J Psychiatry. 2018;175:1137\u201344.","journal-title":"Am J Psychiatry"},{"key":"3015_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-017-1381-4","volume":"17","author":"J Sundquist","year":"2017","unstructured":"Sundquist J, Ohlsson H, Sundquist K, Kendler KS. Common adult psychiatric disorders in Swedish primary care (Where most mental health patients are treated). BMC Psychiatry. 2017;17:235.","journal-title":"BMC Psychiatry"},{"key":"3015_CR29","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1001\/jamapsychiatry.2017.4457","volume":"75","author":"KS Kendler","year":"2018","unstructured":"Kendler KS, Lonn SL, Salvatore J, Sundquist J, Sundquist K. The origin of spousal resemblance for alcohol use disorder. JAMA Psychiatry. 2018;75:280\u20136.","journal-title":"JAMA Psychiatry"},{"key":"3015_CR30","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1001\/jamapsychiatry.2014.2138","volume":"72","author":"KS Kendler","year":"2015","unstructured":"Kendler KS, Ji J, Edwards AC, Ohlsson H, Sundquist J, Sundquist K. An extended Swedish national adoption study of alcohol use disorder. JAMA Psychiatry. 2015;72:211\u20138.","journal-title":"JAMA Psychiatry"},{"key":"3015_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-11-450","volume":"11","author":"JF Ludvigsson","year":"2011","unstructured":"Ludvigsson JF, Andersson E, Ekbom A, Feychting M, Kim JL, Reuterwall C, et al. External review and validation of the Swedish national inpatient register. BMC Public Health. 2011;11:450.","journal-title":"BMC Public Health"},{"key":"3015_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-021-01454-z","volume":"11","author":"KS Kendler","year":"2021","unstructured":"Kendler KS, Ohlsson H, Sundquist J, Sundquist K. The patterns of family genetic risk scores for eleven major psychiatric and substance use disorders in a Swedish national sample. Transl Psychiatry. 2021;11:326.","journal-title":"Transl Psychiatry"},{"key":"3015_CR33","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1017\/S0033291721003317","volume":"53","author":"KS Kendler","year":"2023","unstructured":"Kendler KS, Ohlsson H, Sundquist J, Sundquist K. The impact of sex, age at onset, recurrence, mode of ascertainment and medical complications on the family genetic risk score profiles for alcohol use disorder. Psychol Med. 2023;53:1732\u201340.","journal-title":"Psychol Med"},{"key":"3015_CR34","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1017\/S0033291721005134","volume":"53","author":"KS Kendler","year":"2023","unstructured":"Kendler KS, Ohlsson H, Sundquist J, Sundquist K. The moderation of the genetic risk for alcohol and drug use disorders in a Swedish national sample by the genetic aptitude for educational attainment. Psychol Med. 2023;53:3077\u201384.","journal-title":"Psychol Med"},{"key":"3015_CR35","doi-asserted-by":"publisher","first-page":"3879","DOI":"10.1017\/S0033291722000526","volume":"53","author":"KS Kendler","year":"2023","unstructured":"Kendler KS, Rosmalen JGM, Ohlsson H, Sundquist J, Sundquist K. A distinctive profile of family genetic risk scores in a Swedish national sample of cases of fibromyalgia, irritable bowel syndrome, and chronic fatigue syndrome compared to rheumatoid arthritis and major depression. Psychol Med. 2023;53:3879\u201386.","journal-title":"Psychol Med"},{"key":"3015_CR36","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41588-020-0613-6","volume":"52","author":"ML Hujoel","year":"2020","unstructured":"Hujoel ML, Gazal S, Loh P-R, Patterson N, Price AL. Liability threshold modeling of case\u2013control status and family history of disease increases association power. Nat Genet. 2020;52:541\u20137.","journal-title":"Nat Genet"},{"key":"3015_CR37","doi-asserted-by":"publisher","unstructured":"Dybdahl Krebs M, Appadurai V, Georgii Hellberg K-L, Ohlsson H, Steinbach J, Pedersen E, et al. The relationship between genotype- and phenotype-based estimates of genetic liability to human psychiatric disorders, in practice and in theory. medRxiv [Preprint] 2023; e-pub ahead of print 2023; https:\/\/doi.org\/10.1101\/2023.06.19.23291606v3 (accessed 5 September 2024).","DOI":"10.1101\/2023.06.19.23291606v3"},{"key":"3015_CR38","doi-asserted-by":"publisher","unstructured":"Dybdahl Krebs M, Georgii Hellberg K-L, Lundberg M, Appadurai V, Ohlsson H, Pedersen E, et al. PA-FGRS is a novel estimator of pedigree-based genetic liability that complements genotype-based inferences into the genetic architecture of major depressive disorder. medRxiv [Preprint] 2023; e-pub ahead of print; https:\/\/doi.org\/10.1101\/2023.06.23.23291611; https:\/\/www.medrxiv.org\/content\/10.1101\/2023.06.23.23291611v2 (accessed 7 September 2024).","DOI":"10.1101\/2023.06.23.23291611"},{"key":"3015_CR39","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.1016\/j.ajhg.2024.09.009","volume":"111","author":"M Dybdahl Krebs","year":"2024","unstructured":"Dybdahl Krebs M, Georgii Hellberg KL, Lundberg M, Appadurai V, Ohlsson H, Pedersen E, et al. Genetic liability estimated from large-scale family data improves genetic prediction, risk score profiling, and gene mapping for major depression. Am J Hum Genet. 2024;111:2494\u2013509.","journal-title":"Am J Hum Genet"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-025-03015-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-025-03015-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-025-03015-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T12:02:47Z","timestamp":1757160167000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-025-03015-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,20]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["3015"],"URL":"https:\/\/doi.org\/10.1038\/s41380-025-03015-y","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,20]]},"assertion":[{"value":"15 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All methods were performed in accordance with the relevant guidelines and regulations. Ethics approval for this study was obtained from the Regional Ethical Review Board in Lund (Reference No. 2008\/409 and later amendments), and no participant informed consent was required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}